Skip to main navigation

About
Focus
Pipeline
Patients
Investors
Careers

About
Focus
Pipeline
Patients
Investors
Careers

News Releases

Year

December 4, 2023

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 10, 2023

PDF Version

X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences

November 9, 2023

PDF Version

X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates

November 2, 2023

PDF Version

X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023

November 1, 2023

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 31, 2023

PDF Version

X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome

October 18, 2023

PDF Version

X4 Pharmaceuticals Announces Appointment of Industry Veteran R. Keith Woods to Board of Directors

October 2, 2023

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 19, 2023

PDF Version

X4 Pharmaceuticals to Participate in the Cantor Global Healthcare Conference

September 6, 2023

PDF Version

X4 Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 28

quick links

Quick Links

About
Patients
Investors
Careers

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300

X4 Pharmaceuticals (Austria) GmbH
Helmut-Qualtinger-Gasse 2
A-103 Vienna, Austria Phone: +43.1.395078300

© 2023 X4 Pharmaceuticals, Inc. All rights reserved.

Live - Footer

Terms of Use | Privacy Policy